The present invention is directed to compounds of Formula I: ##STR00001## which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.

 
Web www.patentalert.com

< MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

> Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same

> Microporous materials, methods, and articles for localizing and quantifying analytes
~ 00559